Cite
MLA Citation
Douglas Tremblay et al.. “Ruxolitinib discontinuation in polycythemia vera: Patient characteristics, outcomes, and salvage strategies from a large multi-institutional database.” Leukemia research, vol. 109, 2021, p. . http://access.bl.uk/ark:/81055/vdc_100142336590.0x000053